Keywords: Tumors, Deuterium, gliomaDynamic glucose-enhanced deuterium MRS (DGE 2H-MRS) coupled with Marchenko-Pastur PCA (MPPCA) denoising has been recently applied to immunocompetent mouse glioblastoma subtypes (GL261 and CT2A), demonstrating the ability to measure glucose metabolism through glycolysis and mitochondrial oxidation non-invasively, and its association with tumor proliferation. Here, we extend this approach to DGE Deuterium Metabolic Imaging (DGE-DMI) coupled with tensor MPPCA (tMPPCA) denoising, to map glucose fluxes in the same mouse models of glioblastoma. Our results demonstrate a strong association between glycolytic rates and MRI and histologic features of inter/intra-tumor heterogeneity.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords